NOD2 polymorphisms in CVID: Investigation into associations with gastrointestinal pathology and granulomatous disease by Packwood, K, Ferry, B, Punwani, D, Lopez-Granados, E, Chapel, H

TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis by Gregory, A, Kaur, G, Punwani, D, Felce, J, Davis, S, Fugger, L, Dendrou, C, Attfield, K, Haghikia, A, Lambert, L, Leach, O, Prömel, S, Gold, R, Xifara, D, McVean, G, Butter, F, Mann, M, Poschmann, G, Nielsen, F, Siegel, R, Bell, J

TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. by Gregory, A, Dendrou, C, Attfield, K, Haghikia, A, Xifara, D, Butter, F, Poschmann, G, Kaur, G, Lambert, L, Leach, O, Prömel, S, Punwani, D, Felce, J, Davis, S, Gold, R, Nielsen, F, Siegel, R, Mann, M, Bell, J, McVean, G, Fugger, L